| Financial Year |
March 31 2023 |
| Monetary Funds |
1,626,008,160.78 |
| Held-for-trading Financial Assets |
976,449,550.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,491,920,701.43 |
| Advances to Suppliers |
224,182,762.48 |
| Other Receivables |
355,251,282.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,889,706,566.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
150,330,655.87 |
| Total Current Assets |
9,259,730,285.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,571,670.63 |
| Long-term Equity Investment |
1,108,334,888.27 |
| Investment Properties |
64,867,757.49 |
| Fixed Assetes |
4,946,794,244.45 |
| Under-construction Projects |
1,272,023,326.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,077,142,583.81 |
| R&D expenses |
1,138,843,034.37 |
| Goodwill |
2,071,108,541.00 |
| Long-Term Deferred and Prepaid Expenses |
18,599,509.78 |
| Deferred Income Tax Assets |
259,970,991.35 |
| Other Non-Current Assets |
655,159,049.90 |
| Sub-Total of Non-Current Assets |
13,012,053,686.24 |
| Total Assets |
22,271,783,971.82 |
| Short-Term Loans |
481,610,879.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
228,928,109.25 |
| Accounts Payable |
2,276,531,763.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,347,180.96 |
| Taxes Payable |
203,085,699.14 |
| Interest Payable |
-- |
| Dividend Payable |
40,727,059.41 |
| Other payables |
2,740,536,673.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
516,044,555.74 |
| Other Current Liabilities |
35,241,250.07 |
| Sub-Total of Current Liabilities |
6,886,100,123.83 |
| Long-term Loans |
2,005,881,009.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
189,676,865.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
104,278,441.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,645,448,739.68 |
| Total Liabilities |
9,531,548,863.51 |
| Paid-In Capital(Or Share Stock) |
1,106,042,645.00 |
| Capital Surplus |
2,493,902,966.13 |
| Surplus Reserve |
570,790,305.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,635,026,735.60 |
| Minority Stockholder's Interest |
-75,336,129.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,815,571,238.28 |
| Owner's Equity（Stockholder's Equity） |
12,740,235,108.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,271,783,971.82 |
